ATTR Amyloidosis Treatment Market is driven by Innovation

agregó una foto Health

2025-05-09 07:49:28 -

The ATTR Amyloidosis Treatment Market encompasses therapies focused on transthyretin stabilization and gene-silencing approaches to manage cardiomyopathy and polyneuropathy arising from amyloid fibril deposition. Market products include TTR stabilizers such as tafamidis and diflunisal, RNA interference (RNAi) drugs like patisiran, and antisense oligonucleotides exemplified by inotersen. These...

0 Commentarios 0 Acciones 1K Views 0 Vista previa